EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib vs chemotherapy treatment of physician's choice (TPC) in OlympiAD Meeting Abstract
| Authors: | Robson, M. E.; Ruddy, K. J.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Tung, N. M.; Armstrong, A. C.; Bannister, W.; Goessl, C. D.; Degboe, A.; Hettle, R.; Conte, P. F. |
| Abstract Title: | EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib vs chemotherapy treatment of physician's choice (TPC) in OlympiAD |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 45s |
| Language: | English |
| ACCESSION: | WOS:000442916001067 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.1045 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1045 -- Source: Wos |
